HEADER TRANSPORT PROTEIN 01-FEB-24 8Y66 TITLE CRYO-EM STRUCTURE OF HUMAN URATE TRANSPORTER GLUT9 BOUND TO INHIBITOR TITLE 2 APIGENIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER COMPND 3 MEMBER 9; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: GLUCOSE TRANSPORTER TYPE 9,GLUT-9,URATE TRANSPORTER; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC2A9, GLUT9; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS GLUT9, INHIBITOR, APIGENIN, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR X.J.PAN,Z.L.SHEN,L.XU,G.X.Y.HUANG REVDAT 1 19-JUN-24 8Y66 0 JRNL AUTH Z.SHEN,L.XU,T.WU,H.WANG,Q.WANG,X.GE,F.KONG,G.HUANG,X.PAN JRNL TITL STRUCTURAL BASIS FOR URATE RECOGNITION AND APIGENIN JRNL TITL 2 INHIBITION OF HUMAN GLUT9. JRNL REF NAT COMMUN V. 15 5039 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38866775 JRNL DOI 10.1038/S41467-024-49420-9 REMARK 2 REMARK 2 RESOLUTION. 3.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.280 REMARK 3 NUMBER OF PARTICLES : 296259 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8Y66 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-FEB-24. REMARK 100 THE DEPOSITION ID IS D_1300044970. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : GLUT9 IN COMPLEX WITH INHIBITOR REMARK 245 APIGENIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 6.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -41 REMARK 465 ALA A -40 REMARK 465 SER A -39 REMARK 465 TRP A -38 REMARK 465 SER A -37 REMARK 465 HIS A -36 REMARK 465 PRO A -35 REMARK 465 GLN A -34 REMARK 465 PHE A -33 REMARK 465 GLU A -32 REMARK 465 LYS A -31 REMARK 465 GLY A -30 REMARK 465 GLY A -29 REMARK 465 GLY A -28 REMARK 465 ALA A -27 REMARK 465 ARG A -26 REMARK 465 GLY A -25 REMARK 465 GLY A -24 REMARK 465 SER A -23 REMARK 465 GLY A -22 REMARK 465 GLY A -21 REMARK 465 GLY A -20 REMARK 465 SER A -19 REMARK 465 TRP A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 PRO A -15 REMARK 465 GLN A -14 REMARK 465 PHE A -13 REMARK 465 GLU A -12 REMARK 465 LYS A -11 REMARK 465 GLY A -10 REMARK 465 PHE A -9 REMARK 465 ASP A -8 REMARK 465 TYR A -7 REMARK 465 LYS A -6 REMARK 465 ASP A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 LYS A -1 REMARK 465 GLY A 0 REMARK 465 THR A 1 REMARK 465 ALA A 2 REMARK 465 ARG A 3 REMARK 465 LYS A 4 REMARK 465 GLN A 5 REMARK 465 ASN A 6 REMARK 465 ARG A 7 REMARK 465 ASN A 8 REMARK 465 SER A 9 REMARK 465 LYS A 10 REMARK 465 GLU A 11 REMARK 465 LEU A 12 REMARK 465 GLY A 13 REMARK 465 LEU A 14 REMARK 465 VAL A 15 REMARK 465 PRO A 16 REMARK 465 LEU A 17 REMARK 465 THR A 18 REMARK 465 ASP A 19 REMARK 465 ASP A 20 REMARK 465 THR A 21 REMARK 465 SER A 22 REMARK 465 HIS A 23 REMARK 465 ALA A 24 REMARK 465 GLY A 25 REMARK 465 PRO A 26 REMARK 465 PRO A 27 REMARK 465 GLY A 28 REMARK 465 PRO A 29 REMARK 465 GLY A 30 REMARK 465 ARG A 31 REMARK 465 ALA A 32 REMARK 465 LEU A 33 REMARK 465 LEU A 34 REMARK 465 GLU A 35 REMARK 465 CYS A 36 REMARK 465 ASP A 37 REMARK 465 HIS A 38 REMARK 465 LEU A 39 REMARK 465 ARG A 40 REMARK 465 SER A 41 REMARK 465 GLY A 42 REMARK 465 VAL A 43 REMARK 465 PRO A 44 REMARK 465 GLY A 45 REMARK 465 GLY A 46 REMARK 465 ARG A 47 REMARK 465 ARG A 48 REMARK 465 ARG A 49 REMARK 465 LYS A 50 REMARK 465 ASP A 51 REMARK 465 TRP A 52 REMARK 465 SER A 53 REMARK 465 TYR A 521 REMARK 465 PRO A 522 REMARK 465 PRO A 523 REMARK 465 GLU A 524 REMARK 465 GLU A 525 REMARK 465 LYS A 526 REMARK 465 ILE A 527 REMARK 465 ASP A 528 REMARK 465 SER A 529 REMARK 465 ALA A 530 REMARK 465 VAL A 531 REMARK 465 THR A 532 REMARK 465 ASP A 533 REMARK 465 GLY A 534 REMARK 465 LYS A 535 REMARK 465 ILE A 536 REMARK 465 ASN A 537 REMARK 465 GLY A 538 REMARK 465 ARG A 539 REMARK 465 PRO A 540 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 233 6.23 -68.31 REMARK 500 ASP A 254 -178.51 -68.72 REMARK 500 SER A 445 -6.20 76.50 REMARK 500 ASN A 504 41.32 38.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-38968 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HUMAN URATE TRANSPORTER GLUT9 BOUND TO REMARK 900 INHIBITOR APIGENIN DBREF 8Y66 A 2 540 UNP Q9NRM0 GTR9_HUMAN 2 540 SEQADV 8Y66 MET A -41 UNP Q9NRM0 INITIATING METHIONINE SEQADV 8Y66 ALA A -40 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 SER A -39 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 TRP A -38 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 SER A -37 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 HIS A -36 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 PRO A -35 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLN A -34 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 PHE A -33 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLU A -32 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 LYS A -31 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -30 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -29 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -28 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ALA A -27 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ARG A -26 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -25 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -24 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 SER A -23 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -22 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -21 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -20 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 SER A -19 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 TRP A -18 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 SER A -17 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 HIS A -16 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 PRO A -15 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLN A -14 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 PHE A -13 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLU A -12 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 LYS A -11 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A -10 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 PHE A -9 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ASP A -8 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 TYR A -7 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 LYS A -6 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ASP A -5 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ASP A -4 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ASP A -3 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 ASP A -2 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 LYS A -1 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 GLY A 0 UNP Q9NRM0 EXPRESSION TAG SEQADV 8Y66 THR A 1 UNP Q9NRM0 EXPRESSION TAG SEQRES 1 A 582 MET ALA SER TRP SER HIS PRO GLN PHE GLU LYS GLY GLY SEQRES 2 A 582 GLY ALA ARG GLY GLY SER GLY GLY GLY SER TRP SER HIS SEQRES 3 A 582 PRO GLN PHE GLU LYS GLY PHE ASP TYR LYS ASP ASP ASP SEQRES 4 A 582 ASP LYS GLY THR ALA ARG LYS GLN ASN ARG ASN SER LYS SEQRES 5 A 582 GLU LEU GLY LEU VAL PRO LEU THR ASP ASP THR SER HIS SEQRES 6 A 582 ALA GLY PRO PRO GLY PRO GLY ARG ALA LEU LEU GLU CYS SEQRES 7 A 582 ASP HIS LEU ARG SER GLY VAL PRO GLY GLY ARG ARG ARG SEQRES 8 A 582 LYS ASP TRP SER CYS SER LEU LEU VAL ALA SER LEU ALA SEQRES 9 A 582 GLY ALA PHE GLY SER SER PHE LEU TYR GLY TYR ASN LEU SEQRES 10 A 582 SER VAL VAL ASN ALA PRO THR PRO TYR ILE LYS ALA PHE SEQRES 11 A 582 TYR ASN GLU SER TRP GLU ARG ARG HIS GLY ARG PRO ILE SEQRES 12 A 582 ASP PRO ASP THR LEU THR LEU LEU TRP SER VAL THR VAL SEQRES 13 A 582 SER ILE PHE ALA ILE GLY GLY LEU VAL GLY THR LEU ILE SEQRES 14 A 582 VAL LYS MET ILE GLY LYS VAL LEU GLY ARG LYS HIS THR SEQRES 15 A 582 LEU LEU ALA ASN ASN GLY PHE ALA ILE SER ALA ALA LEU SEQRES 16 A 582 LEU MET ALA CYS SER LEU GLN ALA GLY ALA PHE GLU MET SEQRES 17 A 582 LEU ILE VAL GLY ARG PHE ILE MET GLY ILE ASP GLY GLY SEQRES 18 A 582 VAL ALA LEU SER VAL LEU PRO MET TYR LEU SER GLU ILE SEQRES 19 A 582 SER PRO LYS GLU ILE ARG GLY SER LEU GLY GLN VAL THR SEQRES 20 A 582 ALA ILE PHE ILE CYS ILE GLY VAL PHE THR GLY GLN LEU SEQRES 21 A 582 LEU GLY LEU PRO GLU LEU LEU GLY LYS GLU SER THR TRP SEQRES 22 A 582 PRO TYR LEU PHE GLY VAL ILE VAL VAL PRO ALA VAL VAL SEQRES 23 A 582 GLN LEU LEU SER LEU PRO PHE LEU PRO ASP SER PRO ARG SEQRES 24 A 582 TYR LEU LEU LEU GLU LYS HIS ASN GLU ALA ARG ALA VAL SEQRES 25 A 582 LYS ALA PHE GLN THR PHE LEU GLY LYS ALA ASP VAL SER SEQRES 26 A 582 GLN GLU VAL GLU GLU VAL LEU ALA GLU SER ARG VAL GLN SEQRES 27 A 582 ARG SER ILE ARG LEU VAL SER VAL LEU GLU LEU LEU ARG SEQRES 28 A 582 ALA PRO TYR VAL ARG TRP GLN VAL VAL THR VAL ILE VAL SEQRES 29 A 582 THR MET ALA CYS TYR GLN LEU CYS GLY LEU ASN ALA ILE SEQRES 30 A 582 TRP PHE TYR THR ASN SER ILE PHE GLY LYS ALA GLY ILE SEQRES 31 A 582 PRO PRO ALA LYS ILE PRO TYR VAL THR LEU SER THR GLY SEQRES 32 A 582 GLY ILE GLU THR LEU ALA ALA VAL PHE SER GLY LEU VAL SEQRES 33 A 582 ILE GLU HIS LEU GLY ARG ARG PRO LEU LEU ILE GLY GLY SEQRES 34 A 582 PHE GLY LEU MET GLY LEU PHE PHE GLY THR LEU THR ILE SEQRES 35 A 582 THR LEU THR LEU GLN ASP HIS ALA PRO TRP VAL PRO TYR SEQRES 36 A 582 LEU SER ILE VAL GLY ILE LEU ALA ILE ILE ALA SER PHE SEQRES 37 A 582 CYS SER GLY PRO GLY GLY ILE PRO PHE ILE LEU THR GLY SEQRES 38 A 582 GLU PHE PHE GLN GLN SER GLN ARG PRO ALA ALA PHE ILE SEQRES 39 A 582 ILE ALA GLY THR VAL ASN TRP LEU SER ASN PHE ALA VAL SEQRES 40 A 582 GLY LEU LEU PHE PRO PHE ILE GLN LYS SER LEU ASP THR SEQRES 41 A 582 TYR CYS PHE LEU VAL PHE ALA THR ILE CYS ILE THR GLY SEQRES 42 A 582 ALA ILE TYR LEU TYR PHE VAL LEU PRO GLU THR LYS ASN SEQRES 43 A 582 ARG THR TYR ALA GLU ILE SER GLN ALA PHE SER LYS ARG SEQRES 44 A 582 ASN LYS ALA TYR PRO PRO GLU GLU LYS ILE ASP SER ALA SEQRES 45 A 582 VAL THR ASP GLY LYS ILE ASN GLY ARG PRO HET AGI A 601 20 HETNAM AGI 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE HETSYN AGI APIGENIN FORMUL 2 AGI C15 H10 O5 HELIX 1 AA1 CYS A 54 SER A 76 1 23 HELIX 2 AA2 PRO A 81 GLY A 98 1 18 HELIX 3 AA3 ASP A 102 GLY A 136 1 35 HELIX 4 AA4 ARG A 137 CYS A 157 1 21 HELIX 5 AA5 CYS A 157 GLY A 162 1 6 HELIX 6 AA6 ALA A 163 LEU A 182 1 20 HELIX 7 AA7 VAL A 184 ILE A 192 1 9 HELIX 8 AA8 PRO A 194 GLU A 196 5 3 HELIX 9 AA9 ILE A 197 GLY A 220 1 24 HELIX 10 AB1 LEU A 221 GLY A 226 1 6 HELIX 11 AB2 THR A 230 VAL A 237 5 8 HELIX 12 AB3 ILE A 238 LEU A 249 1 12 HELIX 13 AB4 PRO A 250 LEU A 252 5 3 HELIX 14 AB5 SER A 255 GLU A 262 1 8 HELIX 15 AB6 ASN A 265 GLY A 278 1 14 HELIX 16 AB7 VAL A 282 SER A 298 1 17 HELIX 17 AB8 SER A 303 ALA A 310 1 8 HELIX 18 AB9 VAL A 313 CYS A 330 1 18 HELIX 19 AC1 GLY A 331 ALA A 346 1 16 HELIX 20 AC2 PRO A 349 ALA A 351 5 3 HELIX 21 AC3 LYS A 352 GLY A 379 1 28 HELIX 22 AC4 ARG A 380 LEU A 404 1 25 HELIX 23 AC5 TRP A 410 GLY A 429 1 20 HELIX 24 AC6 ILE A 433 PHE A 442 1 10 HELIX 25 AC7 ARG A 447 LEU A 476 1 30 HELIX 26 AC8 CYS A 480 VAL A 498 1 19 HELIX 27 AC9 THR A 506 LYS A 519 1 14 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000